AACC Booth Presentation: Utility of Anti-Müllerian Hormone as a Marker of Ovarian Reserve
Anti-Müllerian hormone (AMH), a product of growing ovarian follicles, is one of the newest markers of ovarian reserve and has received high praise for its correlation with antral follicle counts, stability across the menstrual cycle, and minimal variation over time. AMH may be a useful piece of the puzzle when determining a patientís responsiveness to in vitro fertilization and other fertilization therapies.
Originally presented July 18, 2012 in Los Angeles, California.
Joely A. Straseski, PhD, MS, MT(ASCP), DABCC
Medical Director, Endocrinology, ARUP Laboratories
Co-Medical Director, Core Laboratory, ARUP Laboratories
Assistant Professor of Pathology, University of Utah School of Medicine
Dr. Straseski is a medical director of endocrinology and co-medical director of the Core Laboratory at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. She received her PhD in pathology and laboratory medicine and a master of science in bacteriology from the University of Wisconsin-Madison, where she also served as a postdoctoral associate in the Department of Pathology. Dr. Straseski completed a postdoctoral fellowship in clinical chemistry at the Johns Hopkins Medical Institutions in Baltimore, Maryland. She has previously been awarded the Past-Presidents' Scholarship by the American Association for Clinical Chemistry, as well as a Distinguished Abstract Award from the National Academy of Clinical Biochemistry. Dr. Straseski is board certified in clinical chemistry by the American Board of Clinical Chemistry.